Phase 3b

Phase 3b

The period of time between submission for approval of a new drug and receipt of marketing authorisation.

Phase 3B

A subcategory of a Phase-3 clinical trial, performed near the time of approval to accumulate additional findings which and may be required as a condition of regulatory authority approval. Dossier review may continue while associated Phase-3B trials are conducted.